Patent · US Active

High penetration prodrug compositions of peptides and peptide-related compounds

US9248109B2 · kind B2 · utility

10Cited by
6References
26Claims
0Family size

Inventors

Key dates

Filing dateNov 8, 2011
Grant dateFeb 2, 2016
Priority date
Expiry dateNov 8, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of peptides and peptide-related compounds, which are capable of crossing biological barriers with higher penetration efficiency comparing to their parent drugs. The HPPs are capable of being converted to parent drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs/HPCs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs/HPCs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.